Form 4 for TARS Tarsus Pharmaceuticals, Inc.
Accepted 2025-03-20 00:00:00 ET · period of report 2025-03-18 · accession 0001819790-25-000058 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-03-20 | 2025-03-18+ | TARS | Neervannan Seshadri | COO | S - Sale | $47.89 | -7,583 | 79.7K | -9% | -$363.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-18 | S | D | 2,605 | $46.29 | 84,660 | D | — | — | |
| 2 | Common | Common Stock | 2025-03-19 | S | D | 2,543 | $47.40 | 82,117 | D | — | — | |
| 3 | Common | Common Stock | 2025-03-20 | S | D | 2,435 | $50.11 | 79,682 | D | — | — |